However, few clinically detectable solid tumors simply vanish, despite the presence of tumor-infiltrating lymphocytes (TIL). The potentially lethal TIL are instead held at bay by immunosuppressive ...

Instil Bio, one of several companies developing tumor-infiltrating lymphocytes, will use its IPO cash to advance its clinical testing plans. Meanwhile, Finch Therapeutics and Gain Therapeutics ...

The collaborative efforts of the First Affiliated Hospital of Zhengzhou University and Grit Biotechnology exemplify the critical role of translational research in advancing cancer care. T cell ...

The biotech industry has been described as the Wild West of the stock market. Although some companies manage to develop and ...

AI models analyzing tumor-infiltrating lymphocytes show promise in predicting outcomes for triple-negative breast cancer, but ...

Researchers at Karolinska Institutet have investigated how well different AI models can predict the prognosis of ...

Researchers at Karolinska Institutet have examined the ability of various AI models to predict the prognosis of ...